Specialty Pharmacy Insights

Limiting Distribution with Unlimited Potential: Avella Explores Why Today’s Most Powerful Therapies are Distributed Through Limited Specialty Pharmacy Networks

The specialty pharmacy industry is relatively young compared to other healthcare sectors, with its origins tracing back to the early 1970s. However, this industry’s explosive growth has certainly made up for its late start. Specialty drug spending ...

Read More

3 Ways the New IMBRUVICA® Formulation Will Have a Big Impact on Patients

In the time since IMBRUVICA® (ibrutinib) was first approved by the FDA in 2013 it has undergone many changes. This includes multiple indication expansions to various types of leukemia and lymphoma, approval as a first-line therapy, and even ...

Read More